Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Daily Dosing for Bedaquiline in Patients with Tuberculosis.

Salinger DH, Nedelman JR, Mendel C, Spigelman M, Hermann DJ.

Antimicrob Agents Chemother. 2019 Aug 26. pii: AAC.00463-19. doi: 10.1128/AAC.00463-19. [Epub ahead of print]

2.

Population Pharmacokinetics of the Antituberculosis Agent Pretomanid.

Salinger DH, Subramoney V, Everitt D, Nedelman JR.

Antimicrob Agents Chemother. 2019 Sep 23;63(10). pii: e00907-19. doi: 10.1128/AAC.00907-19. Print 2019 Oct.

3.

Long-Term Effects on QT Prolongation of Pretomanid Alone and in Combinations in Patients with Tuberculosis.

Li H, Salinger DH, Everitt D, Li M, Del Parigi A, Mendel C, Nedelman JR.

Antimicrob Agents Chemother. 2019 Sep 23;63(10). pii: e00445-19. doi: 10.1128/AAC.00445-19. Print 2019 Oct.

4.

Diagnostics for confounding in PK/PD models for oxcarbazepine.

Nedelman JR, Rubin DB, Sheiner LB.

Stat Med. 2007 Jan 30;26(2):290-308.

PMID:
16615036
5.

On some "disadvantages" of the population approach.

Nedelman JR.

AAPS J. 2005 Oct 5;7(2):E374-82. Review.

6.

Mealtime glucose regulation with nateglinide in healthy volunteers: comparison with repaglinide and placebo.

Kalbag JB, Walter YH, Nedelman JR, McLeod JF.

Diabetes Care. 2001 Jan;24(1):73-7.

PMID:
11194245
7.

An extension of Satterthwaite's approximation applied to pharmacokinetics.

Nedelman JR, Jia X.

J Biopharm Stat. 1998 May;8(2):317-28.

PMID:
9598425
8.

Multiple-dose pharmacokinetics of a long half-life drug: contributions of mathematical modeling.

Nedelman JR, Gibiansky E, Cramer J, Kovarik J, Meligeni J, Robbins B.

Eur J Drug Metab Pharmacokinet. 1997 Apr-Jun;22(2):179-84.

PMID:
9248788
9.

Description of blood pressure changes in patients beginning cyclosporin A therapy.

Charnick SB, Nedelman JR, Chang CT, Hwang DS, Jin J, Moore MA, Wong R, Meligeni J.

Ther Drug Monit. 1997 Feb;19(1):17-24.

PMID:
9029741
10.

Performance of Bailer's method for AUC confidence intervals from sparse non-normally distributed drug concentrations in toxicokinetic studies.

Pai SM, Nedelman JR, Hajian G, Gibiansky E, Batra VK.

Pharm Res. 1996 Sep;13(9):1280-2. No abstract available.

PMID:
8893262
11.

The variance of a better AUC estimator for sparse, destructive sampling in toxicokinetics.

Nedelman JR, Gibiansky E.

J Pharm Sci. 1996 Aug;85(8):884-6. No abstract available.

PMID:
8863282
12.

Errors in time in pharmacokinetic studies.

Jia X, Nedelman JR.

J Biopharm Stat. 1996 Jul;6(3):303-18.

PMID:
8854234
13.

Serial versus sparse sampling in toxicokinetic studies.

Tse FL, Nedelman JR.

Pharm Res. 1996 Jul;13(7):1105-8.

PMID:
8842053
14.

Pharmacokinetics and pharmacodynamics of multiple-dose terbinafine.

Nedelman JR, Gibiansky E, Robbins BA, Cramer JA, Riefler JF, Lin T, Meligeni JA.

J Clin Pharmacol. 1996 May;36(5):452-61.

PMID:
8739024
15.

A nonlinear mixed-effects pharmacokinetic model comparing two formulations of cyclosporine in stable renal transplant patients.

Sallas WM, Nedelman JR, Sheiner LB, Meligeni JA, Robinson WT.

J Pharmacokinet Biopharm. 1995 Oct;23(5):495-514.

PMID:
8656344
16.

Inferring systemic exposure from a pharmacokinetic screen: model-free and model-based approaches.

Nedelman JR, Karara AH, Chang CT, Gibiansky E, McDonald S, Robinson WT.

Stat Med. 1995 May 15-30;14(9-10):955-68; discussion 969-70.

PMID:
7569513
17.

Perspectives in pharmacokinetics. Physiologically based pharmacokinetic modeling as a tool for drug development.

Charnick SB, Kawai R, Nedelman JR, Lemaire M, Niederberger W, Sato H.

J Pharmacokinet Biopharm. 1995 Apr;23(2):217-29. Review.

PMID:
8719238
18.

Applying Bailer's method for AUC confidence intervals to sparse sampling.

Nedelman JR, Gibiansky E, Lau DT.

Pharm Res. 1995 Jan;12(1):124-8. Erratum in: Pharm Res 1996 Jan;13(1):183.

PMID:
7724473
19.

Assessing drug exposure in rodent toxicity studies without satellite animals.

Nedelman JR, Gibiansky E, Tse FL, Babiuk C.

J Pharmacokinet Biopharm. 1993 Jun;21(3):323-34.

PMID:
8258771

Supplemental Content

Loading ...
Support Center